Evidence map›Paper›PMID 21697345›Full record

ArticleThe Journal of general virology2011

prM-antibody renders immature West Nile virus infectious in vivo.

Tonya M Colpitts, Izabela Rodenhuis-Zybert, Bastiaan Moesker, Penghua Wang, Erol Fikrig, Jolanda M Smit

Open access · greenAbstract read
In one paragraph

Article in The Journal of general virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. An ultrapotent human antibody neutralizes all maturation states of Zika virus.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Review
  3. prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Review
  5. Article
  6. Zika virus: mapping and reprogramming the entry.Cell communication and signaling : CCS · 2019
    Article
  7. Article
  8. Article
  9. Structure of the immature Zika virus at 9 Å resolution.Nature structural & molecular biology · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Generation and characterization of a monoclonal antibody against prM protein of West Nile virus.Monoclonal antibodies in immunodiagnosis and immunotherapy · 2014
    Article
  14. Article
  15. Review
  16. Article
  17. West nile virus.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2013
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tonya M ColpittsSection of Infectious Diseases, Department of Internal Medicine, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA.
Izabela Rodenhuis-ZybertSection of Molecular Virology, Department of Medical Microbiology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
Bastiaan MoeskerSection of Molecular Virology, Department of Medical Microbiology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
Penghua WangSection of Infectious Diseases, Department of Internal Medicine, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA.
Erol FikrigSection of Infectious Diseases, Department of Internal Medicine, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA.
Jolanda M SmitSection of Molecular Virology, Department of Medical Microbiology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
Yale University · USUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

IMMUNOHEMATOLOGY/TRANSFUSION MEDICINE RESEARCH TRAININGT32HL007974 · NHLBI · YALE UNIVERSITY · PI JEANNE E HENDRICKSON, Diane S Krause · 2001 to 2026
$8.1M
Immunotherapeutics for Treatment of Flavivirus InfectionU01AI070343 · NIAID · YALE UNIVERSITY · PI FIKRIG, EROL · 2006 to 2010
$6.6M
Training in Parasitology and Vector BiologyT32AI007404 · NIAID · YALE UNIVERSITY · PI TSCHUDI, CHRISTIAN · 1991 to 2017
$3.8M
Howard Hughes Medical InstituteNHLBI NIH HHS T32 HL007974NIAID NIH HHS T32 AI007404NIAID NIH HHS T32 AI07404NIAID NIH HHS U01 AI070343NIAID NIH HHS UO1 AI070343
6 · The paper itself

Abstract

West Nile virus (WNV) is a member of the family Flaviviridae and is a neurotropic pathogen responsible for severe human disease. Flavivirus-infected cells release virus particles that contain variable numbers of precursor membrane (prM) protein molecules at the viral surface. Consequently, antibodies are produced against the prM protein. These antibodies have been shown to activate the infectious potential of fully immature flavivirus particles in vitro. Here, we provide in vivo proof that prM antibodies render immature WNV infectious. Infection with antibody-opsonized immature WNV particles caused disease and death of mice, and infectious WNV was found in the brains and sera.

Indexed as

Antibody-Dependent EnhancementVirus InternalizationAnimalsAntibodies, BlockingAntibodies, ViralBrainDisease Models, AnimalMiceRodent DiseasesSerumViral Envelope ProteinsWest Nile FeverAntibodies, BlockingAntibodies, ViralprM protein, FlavivirusViral Envelope Proteins

Identifiers

PMID21697345
PMCPMC3347797
OpenAlexW2058172590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.